Copyright
©The Author(s) 2024.
World J Cardiol. Aug 26, 2024; 16(8): 436-447
Published online Aug 26, 2024. doi: 10.4330/wjc.v16.i8.436
Published online Aug 26, 2024. doi: 10.4330/wjc.v16.i8.436
Table 2 Characteristics of the studies reviewed for patients after heart valve surgery
Ref. | Study design | Purpose | Population | Male/female | X-clamp time in min | Intervention | Outcomes | Main results |
Thomson Mangnall et al[48], 2014 | Prospective study | To evaluate the HRQoL after heart valve replacement surgery | Rheumatic heart disease (128) | 56/72; 26.7 (12.4) | NA | SF-36 questionnaire (preoperatively and 1, 2, and > 2 years postoperatively) | Significant improvement of HRQoL sustained over time | Preoperative HRQoL was impaired but at 1 year postoperative improved across all domains (P < 0.05) apart from mental health (P = 0.081). At 2 years it remained improved from preoperative measurement, with mental health now significantly better (P = 0.028). By > 2 years follow-up all HRQoL domains, except for mental health, were significantly better than preoperative (P = 0.066) |
Jansen Klomp et al[24], 2016 | Prospective, observational cohort study | To investigate the influence of age on postoperative outcomes and HRQoL 1 year after SAVR | AS age < 80 (597) and AS age ≥ 80 (163) | 363/234 and 85/78; 71 (range: 66-75) and 82 (81-83) | 91 (range: 75-111) and 82 (68-107) | SF-36 questionnaire (PCS and MCS score) | Mortality rates were low in group ≥ 80 years and QoL increased towards normal values | In octogenarians, postoperative delirium was 11.0% vs 6.2% in < 80 years; P = 0.034. Operative mortality was 1.9% vs 2.9%; P = 0.59. The QoL was impaired 30-days after surgery (PCS = 45.01, P < 0.001; MCS = 48.21, P = 0.04) but improved towards or above normal values at 1-year follow-up (PCS = 49.92, P = 0.67, MCS = 52.55, P < 0.001). Age was not associated with a lower PCS (β = 0.08 per year, P = 0.34) or MCS (β = 0.08 per year, P = 0.32) 1 year after surgery |
Baron et al[29], 2017 | Randomized clinical trial | To compare HRQoL among intermediate-risk patients with severe AS treated with either TAVR or SAVR | TAVR (950) and SAVR (883) | 1006/827; 81.4 (6.8) | NA | KCCQ, SF-36 questionnaire and EuroQOL-5D at baseline, 1 month, 1 year, and 2 years | Improvement of health status with both TAVR and SAVR at 2 years of follow up | After 2 years of follow up, both TAVR and SAVR showed significant improvements in both disease-specific (16-22 points on the KCCQ-OS scale) and generic health status (3.9-5.1 points on the SF-36 physical summary scale) |
Kotajarvi et al[34], 2017 | Prospective study | To investigate QoL in patients undergoing TAVR or SAVR, and examine the extent to which patient-centered outcomes compare between frail and non-frail patients | AS (103) | 61/42; 80.6 ± 7.4 | NA | DASI, SF-12 questionnaire and LASA administered before and 3 months after surgery | Frail patients exhibit greater improvement in patients’ self-reported outcomes than non-frail patients | Frail patients improved in DASI and SF-12 PCS scores by 50% and 14%, respectively. SF-12 MCS scores improved in frail compared to non-frail participants (3.6 points vs < 1 point). Physical well-being and QoL measures also increased in frail compared to non-frail participants (21.6 points vs 7.1 points) and (25.1 points vs 8.7 points) respectively |
Olsson et al[25], 2017 | Single-center study | To describe patients’ self-reported outcomes in terms of physical function, symptoms, dependence, HRQoL, and cognitive function after TAVI and SAVR | TAVI (24) and SAVR (24) | 15/9 and 12/12; 81 (range: 60-90) and 80 (61-88) | NA | Katz index of independence in ADL, SF-36 questionnaire, EuroQOL-5D and Mini Mental State Examination on the day before and at 6 months after surgery | No change in cognitive function or dependence and no difference in the size of improvement between groups at 6 months’ follow-up | Symptoms reduced, but breathlessness and fatigue remained, especially in the TAVI group. HRQoL was very low in the TAVI group at baseline but increased in all dimensions except social function |
Blokzijl et al[8], 2021 | Observational, multicenter, cohort study | To explore the effect of SAVR on QoL and the variance with age | SAVR (899) | 583/316; NA | NA | SF-12 or SF-36 questionnaire at baseline and at 1-year follow-up | Patients after SAVR on average improve in physical and mental QoL | Physical health increased from 55 to 66 and mental health from 60 to 66 |
Surman et al[52], 2022 | Prospective study | To report on the prospective outcomes in the areas of depression, QoL, angina, and frailty in SAVR and TAVR patients with AS | TAVR (100), SAVR (100), and CABG (100) | 79/21, 80/20, 79/21; 65.94 (11.6), 82.87 (6.9), 65.90 (10.0) | NA | Improvement in PROMs and frailty in all groups by 3 months postoperative regardless of type of surgery | QoL improved within each group over 12 months (P value = 0.0001). Depression between groups (P value = 0.0395) and within each group was significant (P value = 0.0073 for SAVR and 0.0001 for TAVR). Angina was most frequent in TAVR in the QL (P = 0.0001) and PL (P = 0.0007) domains, and improvement was significant in the QL (SAVR P = 0.0010, TAVR P = 0.0001) and PL (SAVR P = 0.0002, TAVR P = 0.0007) domains in both groups. Frailty improved in both groups but was greatest in TAVR (P = 0.00126) |
- Citation: Raidou V, Mitete K, Kourek C, Antonopoulos M, Soulele T, Kolovou K, Vlahodimitris I, Vasileiadis I, Dimopoulos S. Quality of life and functional capacity in patients after cardiac surgery intensive care unit. World J Cardiol 2024; 16(8): 436-447
- URL: https://www.wjgnet.com/1949-8462/full/v16/i8/436.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i8.436